Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy

Epilepsy and Behavior

Volumn 29, Issue 1, 2013, Pages 144-149

  Peng, Wei Feng ^a   Ding, Jing ^a   Mao, Ling Yan ^a   Li, Xin ^a   Liang, Liang ^a   Chen, Cai Zhong ^a   Cheng, Wei Zhong ^a   Fan, Wei ^a   Wang, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Depression; Epilepsy; Glutamate; Glutamine; Magnetic resonance spectroscopy

Indexed keywords

CREATINE; GLUTAMIC ACID; GLUTAMINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; MALE; METABOLITE; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR;

DEPRESSION; EPILEPSY; GLUTAMATE; GLUTAMINE; MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; ADULT; CREATINE; DEPRESSION; EPILEPSY; FEMALE; FUNCTIONAL LATERALITY; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 84882946907     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.07.004     Document Type: Article

References (38)

1. Ettinger A., Reed M., Cramer J. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 2004, 63:1008-1014.
2. Tellez-Zenteno J.F., Patten S.B., Jette N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
3. Cramer J.A., Blum D., Reed M., Fanning K. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003, 4:515-521.
4. Petrovski S., Szoeke C.E., Jones N.C., Salzberg M.R., Sheffield L.J., Huggins R.M., et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 2010, 75:1015-1021.
5. Kanner A.M., Byrne R., Chicharro A., Wuu J., Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 2009, 72:793-799.
6. Thompson A.W., Miller J.W., Katon W., Chaytor N., Ciechanowski P. Sociodemographic and clinical factors associated with depression in epilepsy. Epilepsy Behav 2009, 14:655-660.
7. Kanner A.M., Schachter S.C., Barry J.J., Hersdorffer D.C., Mula M., Trimble M., et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012, 24:156-168.
8. Seidenberg M., Kelly K.G., Parrish J., Geary E., Dow C., Rutecki P., et al. Ipsilateral and contralateral MRI volumetric abnormalities in chronic unilateral temporal lobe epilepsy and their clinical correlates. Epilepsia 2005, 46:420-430.
9. Arnone D., McIntosh A.M., Ebmeier K.P., Munafo M.R., Anderson I.M. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol 2012, 22:1-16.
10. Shamim S., Hasler G., Liew C., Sato S., Theodore W.H. Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia 2009, 50:1067-1071.
11. Mitchell N.D., Baker G.B. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand 2010, 122:192-210.
12. Paul I.A., Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 2003, 1003:250-272.
13. Caverzasi E., Pichiecchio A., Poloni G.U., Calligaro A., Pasin M., Palesi F., et al. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol 2012, 27:13-22.
14. Nadler J.V. Plasticity of glutamate synaptic mechanisms. Jasper's basic mechanisms of the epilepsies 2012, 1-17. Oxford University Press, Oxford. 4th ed. J.L. Noebels, H.H. Jasper (Eds.).
15. 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 1994, 14:373-382.
16. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993, 13:981-989.
17. O'Donoghue M.F., Duncan J.S., Sander J.W. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 1996, 37:563-571.
18. Zheng Y.P., Zhao J.P., Phillips M., Liu J.B., Cai M.F., Sun S.Q., et al. Validity and reliability of the Chinese Hamilton Depression Rating Scale. Br J Psychiatry 1988, 152:660-664.
19. Katzman R., Zhang M.Y., Ouang-Ya-Qu, Wang Z.Y., Liu W.T., Yu E., et al. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988, 41:971-978.
20. Fiest K.M., Dykeman J., Patten S.B., Wiebe S., Kaplan G.G., Maxwell C.J., et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013, 80:590-599.
21. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003, 54:388-398.
22. Piccinelli M., Wilkinson G. Gender differences in depression. Crit Rev Br J Psychiatry 2000, 177:486-492.
23. Campbell S., Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004, 29:417-426.
24. Quiske A., Helmstaedter C., Lux S., Elger C.E. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000, 39:121-125.
25. Baxendale S.A., Thompson P.J., Duncan J.S. Epilepsy & depression: the effects of comorbidity on hippocampal volume-a pilot study. Seizure 2005, 14:435-438.
26. Briellmann R.S., Hopwood M.J., Jackson G.D. Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry 2007, 78:1226-1230.
27. Finegersh A., Avedissian C., Shamim S., Dustin I., Thompson P.M., Theodore W.H. Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures. Epilepsia 2011, 52:689-697.
28. 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007, 68:364-368.
29. Rosenberg D.R., Macmaster F.P., Mirza Y., Smith J.M., Easter P.C., Banerjee S.P., et al. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry 2005, 58:700-704.
30. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000, 47:305-313.
31. Block W., Traber F., von Widdern O., Metten M., Schild H., Maier W., et al. Proton MR spectroscopy of the hippocampus at 3T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol 2009, 12:415-422.
32. Wang X., Li Y.H., Li M.H., Lu J., Zhao J.G., Sun X.J., et al. Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur Arch Psychiatry Clin Neurosci 2012, 262:33-38.
33. Toro C.T., Hallak J.E., Dunham J.S., Leite J.P., Sakamoto A.C., Guarnieri R., et al. The NR1 N-methyl-d-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms. Epilepsia 2007, 48:2352-2356.
34. Doelken M.T., Mennecke A., Stadlbauer A., Kecskemeti L., Kasper B.S., Struffert T., et al. Multi-voxel magnetic resonance spectroscopy at 3T in patients with idiopathic generalised epilepsy. Seizure 2010, 19:485-492.
35. Simister R.J., McLean M.A., Barker G.J., Duncan J.S. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003, 61:897-902.
36. Andersohn F., Schade R., Willich S.N., Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010, 75:335-340.
37. Arana A., Wentworth C.E., Ayuso-Mateos J.L., Arellano F.M. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010, 363:542-551.
38. Nadkarni S., LaJoie J., Devinsky O. Current treatments of epilepsy. Neurology 2005, 64:S2-S11.